T36.2X5A Adverse effect of chloramphenicol group, initial encounter

Name of the Condition

• Adverse effect of chloramphenicol group, initial encounter

Summary

This condition represents an adverse reaction to chloramphenicol or its derivatives during an initial encounter. It includes unintended harmful effects resulting from exposure to this antibiotic group, requiring clinical assessment and management. Documentation should specify the chloramphenicol agent, nature of the adverse effect, and encounter details.

Causes

Adverse effects may result from hypersensitivity reactions, idiosyncratic responses, or cumulative toxicity. Incorrect administration, drug interactions, or underlying patient factors can also contribute to unintended reactions. Underdosing is not applicable here, as the focus is on adverse effects rather than insufficient therapeutic levels.

Risk Factors

• Prior history of antibiotic allergies or sensitivities.
• Polypharmacy increasing interaction risks.
• Renal or hepatic impairment affecting drug metabolism.
• Pediatric or geriatric populations with altered pharmacokinetics.
• Inadequate patient education on medication use.

Symptoms

• Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain.
• Allergic: Rash, urticaria, anaphylaxis.
• Systemic: Fever, hypotension, organ dysfunction (e.g., bone marrow suppression).
• Neurologic: Dizziness, confusion, seizures, altered mental status.

Diagnosis

Evaluation includes patient history of chloramphenicol use, clinical assessment of symptoms, and exclusion of other causes. Laboratory tests may assess organ function (e.g., liver, kidney) or hematologic parameters. Documentation must confirm the adverse effect and initial encounter context.

Treatment Options

Management focuses on discontinuing the offending agent, supportive care, and addressing specific symptoms. Antihistamines or corticosteroids may treat allergic reactions. Severe cases may require hospitalization for monitoring or organ support.

Prognosis and Follow-Up

Prognosis depends on the severity of the adverse effect and timely intervention. Most mild reactions resolve with discontinuation and supportive care. Follow-up ensures resolution of symptoms and monitors for delayed complications.

Complications

• Severe allergic reactions (e.g., anaphylaxis).
• Organ dysfunction (e.g., hepatotoxicity, bone marrow suppression).
• Persistent symptoms or treatment-related sequelae.

Lifestyle & Prevention

• Educate patients on medication risks and proper use.
• Monitor for early signs of adverse effects during therapy.
• Avoid chloramphenicol in patients with known allergies or contraindications.

When to Seek Professional Help

Seek immediate care for severe symptoms (e.g., anaphylaxis, organ dysfunction) or if symptoms worsen. Follow up with a healthcare provider for persistent or new concerns after discontinuing the medication.

Tips for Medical Coders

Document the specific chloramphenicol agent, nature of the adverse effect, and confirm the encounter is initial. Ensure clinical details support the adverse effect diagnosis and exclude other causes. Code T36.2X5A is used for initial encounters; subsequent encounters use different codes.